Beranda › Penyakit Paru › Tennessee › Nashville
Uji klinis Penyakit Paru di Nashville, TN
10 studi untuk Penyakit Paru mencari peserta di lokasi sekitar Nashville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Menerima pesertaFase 2
- Premier Research Center, LLC, Hendersonville · 13 mi jauhnya
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Menerima pesertaFase 3
- SCRI Oncology Partners, Nashville
American Lung Association (ALA) Lung Health Cohort
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Vanderbilt University Medical Center, Nashville
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
- Sarah Cannon Research Institue, Nashville
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Tennessee Oncology, Nashville
- USO - US Oncology Research Network, Nashville
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Menerima pesertaFase 2
- Vanderbilt University Medical Center, Nashville
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Menerima pesertaFase 3
- Clinical Trials Center of Middle Tennesee LLC, Franklin · 17 mi jauhnya
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
Menerima pesertaFase 2
- SCRI Oncology Partners, Nashville
Cooperative Assessment of Late Effects for SCD Curative Therapies
Menerima pesertaStudi observasional
- Vanderbilt University Medical Center, Nashville
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Menerima pesertaFase 2
- Tristar Bone Marrow Transplant, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
Uji klinis Penyakit Paru di kota lain
- Houston, TX15 studi
- Boston, MA14 studi
- Durham, NC13 studi
- New York City, NY12 studi
- Pittsburgh, PA11 studi
- Miami, FL10 studi
- Dallas, TX10 studi
- Columbus, OH10 studi
- Los Angeles, CA10 studi
- Washington, DC10 studi
- Ann Arbor, MI10 studi
- Birmingham, AL9 studi
Studi lain di Nashville
- Kanker Paru Non-Sel Kecil97 studi
- Kanker Payudara81 studi
- Kanker Metastatik70 studi
- Kanker Kolorektal69 studi
- Kanker (semua jenis)65 studi
- Kanker Ovarium49 studi
- Kanker Prostat43 studi
- Kanker Paru40 studi
- Karsinoma Sel Skuamosa Kepala dan Leher39 studi
- Kanker Pankreas39 studi
- Kanker Endometrium38 studi
- Melanoma33 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.